Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer’s disease: Quinolotacrine hybrids

A new series of quinolotacrine hybrids including cyclopenta- and cyclohexa-quinolotacrine derivatives were designed, synthesized, and assessed as anti-cholinesterase (ChE) agents. The designed derivatives indicated higher inhibitory effect on the acetylcholinesterase (AChE) with IC₅₀ values of 0.285–100 µM compared to butyrylcholinesterase (BChE) with IC₅₀ values of?>?100 µM. Of these compounds, cyclohexa-quinolotacrine hybrids displayed a little better anti-AChE activity than cyclopenta-quinolotacrine hybrids. Compound 8-amino-7-(3-hydroxyphenyl)-5,7,9,10,11,12-hexahydro-6H-pyrano[2,3-b:5,6-c'] diquinolin-6-one (6m) including 3-hydroxyphenyl and cyclohexane ring moieties exhibited the best AChE inhibitory activity with IC₅₀ value of 0.285 µM. The kinetic and molecular docking studies indicated that compound 6m occupied both the catalytic anionic site (CAS) and peripheral anionic site (PAS) of AChE as a mixed inhibitor. Using neuroprotective assay against H₂O₂-induced cell death in PC12 cells, the compound 6h illustrated significant protection among the assessed compounds. In silico ADME studies estimated good drug-likeness for the designed compounds. As a result, these quinolotacrine hybrids can be very encouraging AChE inhibitors to treat Alzheimer’s disease.

Graphic abstract

A novel series of quinolotacrine hybrids were designed, synthesized, and evaluated against AChE and BChE enzymes as potential agents for the treatment of AD. The hybrids showed good to significant inhibitory activity against AChE (0.285–100 μM) compared to butyrylcholinesterase (BChE) with IC₅₀ values of?>?100 μM. Among them, compound 8-amino-7-(3-hydroxyphenyl)-5,7,9,10,11,12-hexahydro-6H-pyrano[2,3-b:5,6-c′] diquinolin-6-one (6 m) bearing 3-hydroxyphenyl moiety and cyclohexane ring exhibited the highest anti-AChE activity with IC₅₀ value of 0.285 μM. The kinetic and molecular docking studies illustrated that compound 6 m is a mixed inhibitor and binds to both the catalytic anionic site (CAS) and peripheral anionic site (PAS) of AChE.

     

Inside-Needle Extraction Method Based on Molecularly Imprinted Polymer for Solid-Phase Dynamic Extraction and Preconcentration of Triazine Herbicides Followed by GC–FID Determination

An inside-needle extraction method was developed through thermal polymerization of atrazine-molecularly imprinted polymer (MIP) on the internal surface of a stainless steel hollow needle, which was oxidized and silylated. The fabricated coating (MIP layer) for the needle was durable and showed very good chemical and thermal stability. It could be mounted on a glass syringe and be directly coupled with gas chromatographic (GC) systems. The parameters being effective on the coating and extraction processes, namely nature of oxidizing agent, silylation time, nature and amount of porogen, template-to-MIP components ratio, polymerization time and temperature, sample volume, flow rate, pH and ionic strength of the sample were investigated and optimized. The extraction needle showed high selectivity as well as a great extraction capacity for triazines. The extraction of atrazine, simazine, cyanazine, ametryn, prometryn and terbutryn using the fabricated extraction needle and followed by GC analysis resulted in detection limits of 2.6, 21, 24, 32, 38 and 42 ng mL⁻¹, respectively. The fabricated needle proved to be applicable to the analysis of real samples by comparing the results obtained for non-spiked and spiked samples of grape juice, tap water and groundwater.

     

Applications of sharpless asymmetric dihydroxylation in the total synthesis of natural products

Sharpless asymmetric dihydroxylation involves the reaction of an alkene with osmium tetroxide in the presence of a chiral quinine ligand to form an optically active vicinal diol. This reaction was primarily developed by Sharpless based on the already known racemic Upjohn dihydroxylation. The chiral diols obtained by Sharpless asymmetric dihydroxylation are important intermediates in organic synthesis. Herein, we emphasise the applications of Sharpless asymmetric dihydroxylation in the total synthesis of natural products.     

Preyssler-type heteropoly acid:A new,mild and efficient catalyst for protection of carbonyl compounds

Preyssler-type heteropoly acid is introduced as a new,mild and efficient catalyst for protection of a variety of carbonyl compounds with 1,3-propane dithiol.     

Synthesis and In Vitro Cytotoxic Activity of Novel Triazole‐Isoxazole Derivatives

New derivatives of triazole‐isoxazole were synthesized through a four‐step reaction starting from various ethyl 4‐aryl‐2,4‐dioxobutanoate derivatives. Finally, all compounds were examined by MTT assays for cytotoxic activity in two human breast cancer cell lines (MCF‐7 and T‐47D).     

An efficient solvent-free synthesis of 2-(alkylamino)-2-oxo-1-arylethyl-6,12-dioxo-6,12-dihydroindolo[1,2-b]isoquinoline-11-carboxylate derivatives via four-component reaction

Molecular Diversity - A one-pot approach for the synthesis of a new series of 2-(alkylamino)-2-oxo-1-arylethyl-6,12-dioxo-6,12-dihydroindolo[1,2-b]isoquinoline-11-carboxylate derivatives via a...     

Synthesis and Cytotoxic Evaluation of Novel 1,2,3‐Triazole‐4‐Linked (2E,6E)‐2‐Benzylidene‐6‐(4‐nitrobenzylidene)cyclohexanones

This work describes the synthesis of novel 1,2,3‐triazole‐4‐linked (2E,6E)‐2‐benzylidene‐6‐(4‐nitrobenzylidene)cyclo‐hexanones starting from cyclohexanone. 1‐(Cyclohex‐1‐en‐1‐yl)piperidine, the enamine from cyclohexanone and piperidine, reacted with 4‐nitrobenzaldehyde to obtain 2‐(4‐nitrobenzylidene)cyclohexanone. Condensation of the latter compound with (prop‐2‐yn‐1‐yloxy)benzaldehyde derivatives under acidic conditions gave (4‐nitrobenzylidene)‐[(prop‐2‐yn‐1‐yloxy)‐benzylidene]cyclohexanones. Finally, ‘click reaction’ of these derivatives and various organic azides led to the title compounds. All compounds were examined by MTT assay for cytotoxic activity in one human breast cancer cell line, MDA‐MB‐231.     

Determination of methamphetamine, amphetamine and ecstasy by inside-needle adsorption trap based on molecularly imprinted polymer followed by GC-FID determination

We have developed a solvent-free and sensitive method for the identification and quantification of methamphetamine (MAMP), amphetamine (AMP) and ecstasy (MDMA) in human urine. It is based on the use of an inside-needle adsorption trap (INAT) and a molecularly imprinted polymer (MIP). The MAMP-MIP layer was coated on the internal surface of a hollow stainless steel needle, which was oxidized and silylated. It was used as the extraction needle. A model solution containing the drugs was slowly passed through the extraction needle. After adsorption of the analytes, the needle was directly transferred to the injector of a gas chromatograph, where the analytes were thermally desorbed, separated by GC, and detected with a flame ionization detector. The method does not require an extraction solvent, is fast and simple. The linear range of the calibration graphs are rather wide, and the limit of detection and the limit of quantification (LOQ) for MAMP are 12 and 40?ng?mL^?1, respectively. The relative standard deviations (RSD%) for six repeated experiments (at 500?ng?mL^?1 of MAMP) is 4.9?%. The relative recoveries obtained for MAMP in spiked human urine samples are in the range of 81–93?%.